Protalix BioTherapeutics
PLX
#8567
Rank
HK$0.96 B
Marketcap
HK$13.16
Share price
1.81%
Change (1 day)
19.67%
Change (1 year)

Market capitalization of Protalix BioTherapeutics (PLX)

Market cap: HK$0.96 Billion

As of November 2024 Protalix BioTherapeutics has a market cap of HK$0.96 Billion. This makes Protalix BioTherapeutics the world's 8567th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Protalix BioTherapeutics from 1997 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$0.96 B-4.49%
2023HK$1.01 B87%
2022HK$0.54 B83.56%
2021HK$0.29 B-68.51%
2020HK$0.93 B147.49%
2019HK$0.37 B4.89%
2018HK$0.36 B-49.94%
2017HK$0.72 B68.99%
2016HK$0.42 B-45.86%
2015HK$0.78 B-40.94%
2014HK$1.33 B-52.63%
2013HK$2.82 B-25.02%
2012HK$3.76 B14.71%
2011HK$3.27 B-47.78%
2010HK$6.27 B51.31%
2009HK$4.14 B284.35%
2008HK$1.07 B-46.26%
2007HK$2.00 B-74.97%
2006HK$8.02 B4076.51%
2005HK$0.19 B4140.21%
2004HK$4.53 M-49.87%
2003HK$9.03 M261.43%
2002HK$2.5 M-52.17%
2001HK$5.22 M-8.86%
2000HK$5.73 M-7.48%
1999HK$6.2 M-86%
1998HK$44.27 M-75.1%
1997HK$0.17 B

End of Day market cap according to different sources

On Nov 22nd, 2024 the market cap of Protalix BioTherapeutics was reported to be:

HK$0.97 Billion
by Nasdaq info icon info icon
HK$0.96 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$22.46 B 2,219.55%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$99.02 B 10,123.08%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.131 T 116,709.20%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$150.99 B 15,487.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel